Abstract:Objective To study the roles of regulated upon activation normal T cell expressed and secreted(RANTES) and monocyte cbemoattractant protein-1 (MCP-1) in human immunodeficien- cy virus-1(HIV 1) infected patients.Methods RANTES and MCP-1 in HIV-1 infected patients, including treated and untreated groups,and healthy control group were determined by enzyme-linked immunosorbent assay(ELISA).The recombinant plasmids,hMCP-pcDNA3.1,bRANTES- peDNA3.1 and hMCP/bRANTES-pcDNA3.1,were constructed and transfected into CHO cells to overexpress the corresponding recombinant proteins,whose chemoattract function was then studied. Results The level of RANTES was (164.3±21.3) pg/mL in healthy control group,(1 224.1±62.0) pg/mL in untreated group and (475.3±36.2) pg/mL in treated group.The level of MCP-1 was (90.6±28.5) pg/mL in healthy control group,(335.0±30.3) pg/mL in untreated group and (807.2±62.6) pg/mL in treated group.In HIV-1 infected patients,the levels of RANTES and MCP-1 were significantly increased.After highly active antiretroviral therapy (HAART),the level of RANTES declined,but MCP-1 increased further.Western blot assay revealed that the three recombinant proteins could be recognized by monoclonal antibodies respectively.All of them could chemoattract human peripheral blood mononuclear cells(PBMCs).And the chemoattractant potency of MCP/RANTES fusion protein was stronger.When the recombinant proteins were used with con- centrations as 50,200,400 and 800 pg/mL,respectively,the number of PBMCs chemoattracted by MCP/RANTES fusion protein was 52×10~4/mL,102×10~4/mL,132×10~4/mL and 184×10~4/mL; the number of PBMCs chemoattracted by RANTES was 27×10~4/mL,51×10~4/mL,65×10~4/mL and 96×10~4/mL;the number of PBMCs chemoattracted by MCP-1 was 18×10~4/mL,44×10~4/mL, 54×10~4/mL and 74×10~4/mL.Conclusion RANTES and MCP-1 may both be involved in the HIV infection process and host immunological reaction against HIV.

Contribution Of Human Alpha-Defensin 1, 2, And 3 To The Anti-Hiv-1 Activity Of Cd8 Antiviral Factor

Contribution of Human Α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor

alpha-defensins released into stimulated CD8+ T-cell supernatants are likely derived from residual granulocytes within the irradiated allogeneic peripheral blood mononuclear cells used as feeders.

USP49 Potently Stabilizes APOBEC3G Protein by Removing Ubiquitin and Inhibits HIV-1 Replication

SAMHD1:a new HIV-1 inhibitory factor

Human Beta-Defensins Induce APOBEC3G Expression by Interacting with Chemokine Receptors, Protecting Highly Susceptible Cells from HIV Infection

E3 Inhibition of HIV Infection in Highly Susceptible Cells with Human Β-Defensins—induction of APOBEC3G Via Chemokine Receptors

Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells

Multifaceted Mechanisms of HIV-1 Entry Inhibition by Human Α-Defensin.

Sub-inhibitory concentrations of human α-defensin potentiate neutralizing antibodies against HIV-1 gp41 pre-hairpin intermediates in the presence of serum.

Human Beta-Defensin 2 and 3 Inhibit HIV-1 Replication in Macrophages

Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity.

Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

The Serum Levels and Roles of Regulated Upon Activation Normal T Cell Expressed and Secreted and Monocyte Chemoattractant Protein-1 in Human Immunodeficiency Virus-1 Infected Patients

Human Neutrophil Alpha-Defensin 4 Inhibits HIV-1 Infection in Vitro.

CCR6 Mediates the Intracellular HIV Inhibitory Activity of Human Beta-Defensin 2

Quantifying the Contribution of Fc-mediated Effector Functions to the Antiviral Activity of Anti-Hiv-1 IgG1 Antibodies in Vivo.

Anti-HIV Activity of Human Defensin 5 in Primary CD4+ T Cells under Serum-Deprived Conditions is a Consequence of Defensin-Mediated Cytotoxicity

Human Α‐defensins Are Immune‐related Kv1.3 Channel Inhibitors: New Support for Their Roles in Adaptive Immunity

Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment

Structural Basis of Antagonism of Human APOBEC3F by HIV-1 Vif